CMS To Help Build National FDG-PET Cancer Registry, Will Cover Trials
This article was originally published in The Gray Sheet
Executive Summary
CMS plans to work with stakeholders to develop a national registry as well as small studies to determine the clinical utility of FDG-PET in the management of brain, ovarian, pancreatic and small-cell lung cancers